AKSAN, F. Et Al. 2024. S1092 Continuing or Discontinuing Mesalamine in Crohn’s Disease? A Multinational, Propensity-Matched, Retrospective Cohort Study. American College of Gastroenterology 2024 Annual Scientific Meeting , (Turkey), 773-774.

AKSAN, F., TANRIVERDİ, L. H., & Aroniadis, O. C., (2024). S1092 Continuing or Discontinuing Mesalamine in Crohn’s Disease? A Multinational, Propensity-Matched, Retrospective Cohort Study . American College of Gastroenterology 2024 Annual Scientific Meeting (pp.773-774). , Turkey

AKSAN, FEYZULLAH, LOKMAN HEKİM TANRIVERDİ, And Olga C. Aroniadis. "S1092 Continuing or Discontinuing Mesalamine in Crohn’s Disease? A Multinational, Propensity-Matched, Retrospective Cohort Study," American College of Gastroenterology 2024 Annual Scientific Meeting, Turkey, 2024

AKSAN, FEYZULLAH Et Al. "S1092 Continuing or Discontinuing Mesalamine in Crohn’s Disease? A Multinational, Propensity-Matched, Retrospective Cohort Study." American College of Gastroenterology 2024 Annual Scientific Meeting , Turkey, pp.773-774, 2024

AKSAN, F. TANRIVERDİ, L. H. And Aroniadis, O. C. (2024) . "S1092 Continuing or Discontinuing Mesalamine in Crohn’s Disease? A Multinational, Propensity-Matched, Retrospective Cohort Study." American College of Gastroenterology 2024 Annual Scientific Meeting , Turkey, pp.773-774.

@conferencepaper{conferencepaper, author={FEYZULLAH AKSAN Et Al. }, title={S1092 Continuing or Discontinuing Mesalamine in Crohn’s Disease? A Multinational, Propensity-Matched, Retrospective Cohort Study}, congress name={American College of Gastroenterology 2024 Annual Scientific Meeting}, city={}, country={Turkey}, year={2024}, pages={773-774} }